Fortress Historical Balance Sheet

FBIO Stock

USD 1.88 0.07 3.87%

Trend analysis of Fortress Biotech balance sheet accounts such as Short and Long Term Debt Total of 59.3 M or Other Current Liab of 21.9 M provides information on Fortress Biotech's total assets, liabilities, and equity, which is the actual value of Fortress Biotech to its prevalent stockholders. By breaking down trends over time using Fortress Biotech balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Fortress Biotech latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Fortress Biotech is a good buy for the upcoming year.

Fortress Biotech Inventory

15.15 Million

Build AI portfolio with Fortress Stock

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fortress Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

To learn how to invest in Fortress Stock, please use our How to Invest in Fortress Biotech guide.

About Fortress Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Fortress Biotech at a specified time, usually calculated after every quarter, six months, or one year. Fortress Biotech Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Fortress Biotech and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Fortress currently owns. An asset can also be divided into two categories, current and non-current.

Fortress Biotech Balance Sheet Chart

At this time, Fortress Biotech's Cash And Short Term Investments are very stable compared to the past year. As of the 5th of August 2025, Liabilities And Stockholders Equity is likely to grow to about 172.2 M, while Short and Long Term Debt Total is likely to drop about 59.3 M.

Common Stock Shares Outstanding Total Assets Short Long Term Debt Total Other Current Liab

Add Fundamental

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Total Assets

Total assets refers to the total amount of Fortress Biotech assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Fortress Biotech books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Most accounts from Fortress Biotech's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Fortress Biotech current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fortress Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

To learn how to invest in Fortress Stock, please use our How to Invest in Fortress Biotech guide.At this time, Fortress Biotech's Cash And Short Term Investments are very stable compared to the past year. As of the 5th of August 2025, Liabilities And Stockholders Equity is likely to grow to about 172.2 M, while Short and Long Term Debt Total is likely to drop about 59.3 M.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	127.3M	88.6M	76.0M	59.3M
Total Assets	294.3M	167.5M	144.2M	172.2M

Short Long Term Debt Total Total Assets

Fortress Biotech balance sheet Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Property Plant Equipment	Preferred Stock Total Equity	Common Stock Total Equity	Retained Earnings Total Equity
Common Stock Shares Outstanding		0.1	0.27	0.03	0.29	-0.18	0.24	0.33	-0.7	0.32	0.02	0.26	-0.11	-0.23	0.27	0.0	0.29	0.01	0.48	0.3	0.06	-0.24	0.72	-0.24	-0.03	-0.47
Total Assets	0.1		0.76	0.57	0.79	0.62	0.86	-0.64	-0.64	0.71	0.94	0.81	0.16	0.21	0.72	0.95	0.76	0.42	0.75	0.81	0.98	0.25	0.66	-0.4	0.25	-0.81
Short Long Term Debt Total	0.27	0.76		0.48	0.83	0.1	0.92	-0.07	-0.82	0.85	0.59	0.83	0.22	0.13	0.99	0.6	1.0	0.38	0.86	0.95	0.68	0.45	0.74	-0.35	0.49	-0.91
Other Current Liab	0.03	0.57	0.48		0.83	0.07	0.41	-0.15	-0.46	0.59	0.39	0.58	0.22	0.41	0.51	0.41	0.46	0.68	0.49	0.68	0.53	0.25	0.44	-0.14	0.26	-0.53
Total Current Liabilities	0.29	0.79	0.83	0.83		0.16	0.79	-0.22	-0.8	0.91	0.62	0.78	0.08	0.13	0.82	0.62	0.82	0.47	0.85	0.96	0.73	0.2	0.78	-0.26	0.24	-0.86
Total Stockholder Equity	-0.18	0.62	0.1	0.07	0.16		0.3	-0.88	-0.07	0.09	0.75	0.24	-0.07	0.05	0.04	0.76	0.11	0.04	0.27	0.13	0.69	-0.17	0.15	-0.41	-0.24	-0.23
Property Plant And Equipment Net	0.24	0.86	0.92	0.41	0.79	0.3		-0.35	-0.77	0.86	0.78	0.81	0.02	-0.06	0.86	0.77	0.93	0.2	0.84	0.9	0.81	0.24	0.77	-0.27	0.27	-0.88
Net Debt	0.33	-0.64	-0.07	-0.15	-0.22	-0.88	-0.35		-0.03	-0.18	-0.82	-0.19	0.19	0.05	0.0	-0.81	-0.08	0.02	-0.19	-0.16	-0.73	0.13	-0.1	0.18	0.25	0.17
Retained Earnings	-0.7	-0.64	-0.82	-0.46	-0.8	-0.07	-0.77	-0.03		-0.8	-0.49	-0.73	-0.08	0.06	-0.81	-0.48	-0.83	-0.28	-0.93	-0.85	-0.57	-0.09	-0.96	0.37	-0.23	0.95
Accounts Payable	0.32	0.71	0.85	0.59	0.91	0.09	0.86	-0.18	-0.8		0.6	0.7	0.02	-0.08	0.83	0.58	0.86	0.15	0.84	0.93	0.66	0.16	0.75	-0.25	0.2	-0.85
Cash	0.02	0.94	0.59	0.39	0.62	0.75	0.78	-0.82	-0.49	0.6		0.6	-0.03	0.01	0.53	1.0	0.6	0.19	0.61	0.63	0.98	0.09	0.56	-0.35	0.07	-0.67
Non Current Assets Total	0.26	0.81	0.83	0.58	0.78	0.24	0.81	-0.19	-0.73	0.7	0.6		0.43	0.38	0.85	0.61	0.86	0.52	0.78	0.85	0.7	0.35	0.66	-0.37	0.39	-0.83
Non Currrent Assets Other	-0.11	0.16	0.22	0.22	0.08	-0.07	0.02	0.19	-0.08	0.02	-0.03	0.43		0.77	0.31	0.03	0.22	0.47	0.06	0.16	0.07	0.64	-0.13	-0.3	0.65	-0.18
Other Assets	-0.23	0.21	0.13	0.41	0.13	0.05	-0.06	0.05	0.06	-0.08	0.01	0.38	0.77		0.23	0.07	0.11	0.81	-0.01	0.13	0.14	0.66	-0.21	-0.19	0.63	-0.05
Long Term Debt	0.27	0.72	0.99	0.51	0.82	0.04	0.86	0.0	-0.81	0.83	0.53	0.85	0.31	0.23		0.54	0.99	0.44	0.84	0.94	0.64	0.49	0.7	-0.37	0.54	-0.89
Cash And Short Term Investments	0.0	0.95	0.6	0.41	0.62	0.76	0.77	-0.81	-0.48	0.58	1.0	0.61	0.03	0.07	0.54		0.6	0.25	0.6	0.63	0.99	0.15	0.54	-0.37	0.12	-0.67
Non Current Liabilities Total	0.29	0.76	1.0	0.46	0.82	0.11	0.93	-0.08	-0.83	0.86	0.6	0.86	0.22	0.11	0.99	0.6		0.35	0.87	0.95	0.68	0.4	0.75	-0.35	0.45	-0.92
Other Current Assets	0.01	0.42	0.38	0.68	0.47	0.04	0.2	0.02	-0.28	0.15	0.19	0.52	0.47	0.81	0.44	0.25	0.35		0.3	0.42	0.36	0.62	0.21	-0.21	0.65	-0.36
Other Stockholder Equity	0.48	0.75	0.86	0.49	0.85	0.27	0.84	-0.19	-0.93	0.84	0.61	0.78	0.06	-0.01	0.84	0.6	0.87	0.3		0.9	0.69	0.12	0.88	-0.42	0.19	-0.95
Total Liab	0.3	0.81	0.95	0.68	0.96	0.13	0.9	-0.16	-0.85	0.93	0.63	0.85	0.16	0.13	0.94	0.63	0.95	0.42	0.9		0.74	0.32	0.79	-0.32	0.36	-0.93
Total Current Assets	0.06	0.98	0.68	0.53	0.73	0.69	0.81	-0.73	-0.57	0.66	0.98	0.7	0.07	0.14	0.64	0.99	0.68	0.36	0.69	0.74		0.2	0.62	-0.38	0.19	-0.75
Common Stock	-0.24	0.25	0.45	0.25	0.2	-0.17	0.24	0.13	-0.09	0.16	0.09	0.35	0.64	0.66	0.49	0.15	0.4	0.62	0.12	0.32	0.2		-0.09	-0.17	0.97	-0.24
Property Plant Equipment	0.72	0.66	0.74	0.44	0.78	0.15	0.77	-0.1	-0.96	0.75	0.56	0.66	-0.13	-0.21	0.7	0.54	0.75	0.21	0.88	0.79	0.62	-0.09		-0.26	0.06	-0.9
Preferred Stock Total Equity	-0.24	-0.4	-0.35	-0.14	-0.26	-0.41	-0.27	0.18	0.37	-0.25	-0.35	-0.37	-0.3	-0.19	-0.37	-0.37	-0.35	-0.21	-0.42	-0.32	-0.38	-0.17	-0.26		-0.19	0.42
Common Stock Total Equity	-0.03	0.25	0.49	0.26	0.24	-0.24	0.27	0.25	-0.23	0.2	0.07	0.39	0.65	0.63	0.54	0.12	0.45	0.65	0.19	0.36	0.19	0.97	0.06	-0.19		-0.34
Retained Earnings Total Equity	-0.47	-0.81	-0.91	-0.53	-0.86	-0.23	-0.88	0.17	0.95	-0.85	-0.67	-0.83	-0.18	-0.05	-0.89	-0.67	-0.92	-0.36	-0.95	-0.93	-0.75	-0.24	-0.9	0.42	-0.34

Click cells to compare fundamentals

Fortress Biotech Account Relationship Matchups

Fortress Biotech balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Common Stock Shares Outstanding	4.8M	5.4M	5.9M	8.1M	20.8M	21.8M
Total Assets	328.8M	396.5M	294.3M	167.5M	144.2M	172.2M
Short Long Term Debt Total	89.1M	75.0M	127.3M	88.6M	76.0M	59.3M
Other Current Liab	9.3M	43.2M	56.4M	39.8M	12.4M	21.9M
Total Current Liabilities	51.8M	101.0M	127.7M	84.9M	71.4M	49.0M
Total Stockholder Equity	100.3M	108.7M	41.7M	22.5M	22.7M	21.6M
Property Plant And Equipment Net	32.4M	34.1M	33.0M	23.5M	17.1M	14.9M
Net Debt	(144.3M)	(230.8M)	(50.9M)	7.7M	18.7M	19.6M
Retained Earnings	(482.8M)	(547.5M)	(634.2M)	(694.9M)	(740.9M)	(703.8M)
Accounts Payable	11.4M	47.4M	57.2M	34.8M	31.6M	18.3M
Cash	233.4M	305.7M	178.3M	80.9M	57.3M	109.1M
Non Current Assets Total	67.3M	50.0M	63.9M	50.5M	53.9M	40.2M
Non Currrent Assets Other	2.7M	3.4M	3.7M	6.7M	4.9M	9.4M
Other Assets	16.4M	17.7M	2.7M	3.4M	3.9M	3.7M
Long Term Debt	59.0M	46.6M	93.1M	60.9M	58.0M	43.8M
Cash And Short Term Investments	233.4M	305.7M	178.3M	80.9M	57.3M	113.1M
Liabilities And Stockholders Equity	328.8M	396.5M	294.3M	167.5M	144.2M	172.2M
Non Current Liabilities Total	83.9M	69.6M	116.6M	81.0M	74.5M	54.7M
Other Current Assets	12.0M	7.1M	9.7M	10.5M	8.3M	8.9M
Other Stockholder Equity	583M	656.0M	675.8M	717.4M	763.6M	395.4M
Total Liab	131.8M	170.6M	244.3M	165.9M	145.9M	100.1M
Total Current Assets	261.6M	346.5M	230.4M	117.0M	90.4M	134.5M
Common Stock	95K	101K	110K	15K	28K	26.6K
Property Plant Equipment	12.0M	12.4M	32.4M	34.1M	39.2M	41.1M
Noncontrolling Interest In Consolidated Entity	17.9M	46.3M	96.7M	117.2M	134.8M	141.5M
Common Stock Total Equity	717K	574K	95K	101K	116.2K	226.3K
Retained Earnings Total Equity	(396.3M)	(436.2M)	(482.8M)	(547.5M)	(492.7M)	(468.1M)
Inventory	1.4M	9.9M	14.2M	10.2M	14.4M	15.2M
Intangible Assets	14.6M	12.6M	27.2M	20.3M	31.9M	33.5M
Other Liab	5.2M	2.1M	1.9M	2.0M	2.3M	2.7M
Net Tangible Assets	1.9M	26.2M	85.7M	96.1M	110.5M	58.3M
Net Receivables	19.3M	23.8M	28.3M	15.4M	10.4M	11.9M
Capital Surpluse	397.4M	461.9M	583M	656.0M	754.4M	386.6M
Property Plant And Equipment Gross	32.4M	15.1M	33.0M	32.4M	29.2M	17.4M
Short Term Debt	6.4M	7.4M	12.6M	9.5M	3.2M	3.1M

Pair Trading with Fortress Biotech

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Fortress Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fortress Biotech will appreciate offsetting losses from the drop in the long position's value.

Moving against Fortress Stock

0.58	CDIOW	Cardio Diagnostics	Pair Corr
0.5	VCYT	Veracyte Earnings Call Tomorrow	Pair Corr
0.36	DRUG	Bright Minds Biosciences	Pair Corr

The ability to find closely correlated positions to Fortress Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Fortress Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Fortress Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Fortress Biotech to buy it.

The correlation of Fortress Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Fortress Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Fortress Biotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Fortress Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Fortress Biotech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Fortress Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Fortress Biotech Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Fortress Biotech Stock:

How To Invest In Fortress

Details

Is Fortress Stock a good investment?

Details

What is Fortress Biotech's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

To learn how to invest in Fortress Stock, please use our How to Invest in Fortress Biotech guide.

You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fortress Biotech. If investors know Fortress will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fortress Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(2.13)

Revenue Per Share

2.501

Quarterly Revenue Growth

0.008

Return On Assets

(0.32)

Return On Equity

(7.46)

The market value of Fortress Biotech is measured differently than its book value, which is the value of Fortress that is recorded on the company's balance sheet. Investors also form their own opinion of Fortress Biotech's value that differs from its market value or its book value, called intrinsic value, which is Fortress Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fortress Biotech's market value can be influenced by many factors that don't directly affect Fortress Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Fortress Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fortress Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fortress Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC

Fortress Historical Balance Sheet

Fortress Biotech Inventory

15.15 Million

About Fortress Balance Sheet Analysis

Fortress Biotech Balance Sheet Chart

Common Stock Shares Outstanding

Total Assets

Fortress Biotech balance sheet Correlations

Fortress Biotech Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Fortress Biotech balance sheet Accounts

Pair Trading with Fortress Biotech

Moving against Fortress Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Liabilities Total	+ 1.0	Short Long Term Debt Total
Cash And Short Term Investments	+ 1.0	Cash
Long Term Debt	+ 0.99	Short Long Term Debt Total
Non Current Liabilities Total	+ 0.99	Long Term Debt
Total Current Assets	+ 0.99	Cash And Short Term Investments
Total Current Assets	+ 0.98	Total Assets

Property Plant Equipment	- 0.96	Retained Earnings
Retained Earnings Total Equity	- 0.95	Other Stockholder Equity
Retained Earnings Total Equity	- 0.93	Total Liab
Other Stockholder Equity	- 0.93	Retained Earnings
Retained Earnings Total Equity	- 0.92	Non Current Liabilities Total
Retained Earnings Total Equity	- 0.91	Short Long Term Debt Total